Study Phase III to Evaluate the Noninferiority of Heavy Levobupivacaine 50% Enantiomeric Excess (Levobupivacaine S75:R25) Compared to Racemic Heavy Bupivacaine (Bupivacaine S50:R50) in Spinal Anesthesia for Lower Limb Orthopedic Procedures

Trial Profile

Study Phase III to Evaluate the Noninferiority of Heavy Levobupivacaine 50% Enantiomeric Excess (Levobupivacaine S75:R25) Compared to Racemic Heavy Bupivacaine (Bupivacaine S50:R50) in Spinal Anesthesia for Lower Limb Orthopedic Procedures

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 18 Jul 2017

At a glance

  • Drugs Levobupivacaine (Primary) ; Bupivacaine; Morphine
  • Indications Perioperative pain; Postoperative pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Cristalia
  • Most Recent Events

    • 18 Jul 2017 Planned primary completion date changed from 30 Oct 2016 to 1 Dec 2016.
    • 18 Jul 2017 Planned initiation date changed from 1 Oct 2016 to 1 Nov 2016.
    • 18 Jul 2017 Status changed from suspended to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top